Loading…
CIK 0002052213 • 3 13F filings • Feb 17, 2026 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("elmind-capital-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 3 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALECTOR INC | COM | $1.4M | 0.4%Prev: 0.5% | 900,000 SH | Decreased |
| AMYLYX PHARMACEUTICALS INC | COM | $1.4M | 0.4%Prev: 0.5% | 112,000 SH | Decreased |
| APELLIS PHARMACEUTICALS INC | COM | $1.3M | 0.4% | 50,000 SH | New |
| BEAM THERAPEUTICS INC | COM | $13.2M | 3.9%Prev: 4.1% | 476,338 SH | Decreased |
| BIOCRYST PHARMACEUTICALS INC | COM | $16.8M | 4.9%Prev: 1.3% | 2,150,000 SH | Increased+1,630,000 SH |
| BIOMARIN PHARMACEUTICAL INC | COM | $4.9M | 1.4%Prev: 0.7% | 82,000 SH | Increased+35,000 SH |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | $23.5M | 6.9%Prev: 9.3% | 865,000 SH | Decreased-125,000 SH |
| CG ONCOLOGY INC | COM | $20.4M | 6.0% | 492,500 SH | New |
| COGENT BIOSCIENCES INC | COM | $41.6M | 12.3%Prev: 11.4% | 1,170,740 SH | Decreased |
| CULLINAN THERAPEUTICS INC | COM | $3.2M | 0.9%Prev: 3.2% | 310,000 SH | Decreased-380,000 SH |
| CYTOMX THERAPEUTICS INC | COM | $3.0M | 0.9% | 700,000 SH | New |
| DESIGN THERAPEUTICS INC | COM | $2.0M | 0.6%Prev: 0.4% | 207,900 SH | Increased+100,000 SH |
| DYNAVAX TECHNOLOGIES CORP | COM NEW | $10.5M | 3.1% | 679,900 SH | New |
| EDGEWISE THERAPEUTICS INC | COM | $744K | 0.2% | 30,000 SH | New |
| ENGENE HOLDINGS INC | COM | $1.9M | 0.6% | 210,000 SH | New |
| IMMUNOCORE HLDGS PLC | ADS | $2.0M | 0.6%Prev: 0.6% | 58,248 SH | Decreased-22,895 SH |
| KALVISTA PHARMACEUTICALS INC | COM | $12.9M | 3.8% | 801,300 SH | New |
| KRYSTAL BIOTECH INC | COM | $5.4M | 1.6%Prev: 2.1% | 22,000 SH | Decreased |
| LIQUIDIA CORPORATION | COM NEW | $3.1M | 0.9% | 90,000 SH | New |
| MBX BIOSCIENCES INC | COM | $6.7M | 2.0%Prev: 1.3% | 211,000 SH | Increased+120,000 SH |
| NURIX THERAPEUTICS INC | COM | $8.7M | 2.6%Prev: 2.8% | 460,000 SH | Decreased |
| PHARVARIS N V | COM | $13.2M | 3.9%Prev: 4.6% | 475,750 SH | Decreased-50,000 SH |
| PROTAGONIST THERAPEUTICS INC | COM | $3.3M | 1.0%Prev: 1.2% | 38,000 SH | Decreased |
| RELAY THERAPEUTICS INC | COM | $4.5M | 1.3%Prev: 6.9% | 536,946 SH | Decreased-928,333 SH |
| SUPERNUS PHARMACEUTICALS INC | COM | $994K | 0.3% | 20,000 SH | New |
| SYNDAX PHARMACEUTICALS INC | COM | $39.0M | 11.5%Prev: 10.2% | 1,855,000 SH | Decreased |
| TRAVERE THERAPEUTICS INC | COM | $4.2M | 1.2%Prev: 4.2% | 110,000 SH | Decreased-182,600 SH |
| TYRA BIOSCIENCES INC | COM | $9.2M | 2.7%Prev: 0.2% | 350,000 SH | Increased+330,000 SH |
| UNITED THERAPEUTICS CORP DEL | COM | $5.4M | 1.6%Prev: 2.0% | 11,000 SH | Decreased-4,000 SH |
| UROGEN PHARMA LTD | COM | $2.3M | 0.7%Prev: 1.1% | 100,000 SH | Decreased-20,000 SH |
| VAXCYTE INC | COM | $13.4M | 4.0%Prev: 6.6% | 291,500 SH | Decreased-160,840 SH |
| VERA THERAPEUTICS INC | CL A | $24.4M | 7.2%Prev: 4.7% | 482,500 SH | Increased+45,982 SH |
| VIRIDIAN THERAPEUTICS INC | COM | $26.7M | 7.9%Prev: 4.5% | 858,631 SH | Increased-126,300 SH |
| WAVE LIFE SCIENCES LTD | SHS | $7.6M | 2.2%Prev: 0.3% | 447,846 SH | Increased+270,000 SH |
| 13F-HR |
| 0001013594-26-000602 |
| $352.2M |
| View |